Matthew Thomas Howes is a post-doctoral fellow at PHF Science in New Zealand. He completed his undergraduate and postgraduate training at the University of Otago in New Zealand, completing a BSc (Hons) and PhD in pharmacology and toxicology. His current research investigates drug-induced liver injury using a liver-on-a-chip. Previously, he has investigated therapeutics for migraine, dietary triggers of metabolic disease, and the effects of nitrates on colorectal cancer. He is a member of the Society of Toxicology and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists.
Matthew Thomas Howes is a post-doctoral fellow at PHF Science in New Zealand. He completed his undergraduate and postgraduate training at the University of Otago in New Zealand, completing a BSc (Hons) and PhD in pharmacology and toxicology. His current research investigates drug-induced liver injury using a liver-on-a-chip. Previously, he has investigated therapeutics for migraine, dietary triggers of metabolic disease, and the effects of nitrates on colorectal cancer. He is a member of the Society of Toxicology and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists.